CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning Balance at Dec. 31, 2023	$ 121,195	$ 23	$ 237,675	$ (83)	$ (116,420)
Beginning Balance, Shares at Dec. 31, 2023		22,522,644
Exercise of common stock options	79		79
Exercise of common stock options, Shares		20,277
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax	(166)		(166)
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax, Shares		94,618
Stock-based compensation expense	3,344		3,344
Unrealized (loss) gain on available-for-sale investments, net of tax	13			13
Net Income (Loss)	(16,486)				(16,486)
Ending Balance at Mar. 31, 2024	107,979	$ 23	240,932	(70)	(132,906)
Ending Balance, Shares at Mar. 31, 2024		22,637,539
Beginning Balance at Dec. 31, 2024	176,786	$ 31	373,284	447	(196,976)
Beginning Balance, Shares at Dec. 31, 2024		31,231,264
Exercise of common stock options	$ 1		1
Exercise of common stock options, Shares	225	225
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax	$ (344)		(344)
Issuance of common stock upon vesting of restricted stock units, net of shares withheld for tax, Shares		120,578
Stock-based compensation expense	3,791		3,791
Unrealized (loss) gain on available-for-sale investments, net of tax	(164)			(164)
Net Income (Loss)	(19,680)				(19,680)
Ending Balance at Mar. 31, 2025	$ 160,390	$ 31	$ 376,732	$ 283	$ (216,656)
Ending Balance, Shares at Mar. 31, 2025		31,352,067